Your session is about to expire
← Back to Search
Electrophysiology Mapping System
VIVO™ Accuracy Study
N/A
Waitlist Available
Research Sponsored by Catheter Precision. Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 day
Awards & highlights
No Placebo-Only Group
Summary
A multi-center study designed to assess the accuracy of VIVO™ in determining the location of a PVC/VT foci in comparison to an electroanatomical mapping system.
Eligible Conditions
- Premature Ventricular Contractions
- Ventricular Tachycardia
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1 day
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 day
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Accuracy of correctly identifying PVC or VT origin
Secondary study objectives
Accuracy of correctly identifying known pacing sites
Number of adverse events
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Single ArmExperimental Treatment1 Intervention
All patients will undergo standard of care ablation procedures. VIVO™ results will be compared to that of standard of care results, but will not be used in diagnosis or treatment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
VIVO™
2018
N/A
~50
Find a Location
Who is running the clinical trial?
Catheter Precision. Inc.Lead Sponsor
1 Previous Clinical Trials
125 Total Patients Enrolled
Missiaen HuckStudy DirectorCatheter Precision. Inc.